Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Cereno Scientific
Company

Cereno Scientific

Tracked across 1 events · 7 articles · First seen Feb 04, 2026 · Last active Feb 04, 2026

Sentiment
50
Attention
2
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 50
Business
Cereno Scientific Broadens CS014 Focus to PH-ILD
Cereno Scientific is broadening the development focus of its HDAC inhibitor CS014 to pulmonary hypertension associated with interstitial lung disease (PH-ILD). This strategic shift aims to strengthen the development potential of CS014, address a high unmet medical need, and potentially accelerate its market entry at a lower cost.
Feb 04, 2026 · 7 articles
Relationships (3)
DNB Carnegie Investment Bank Certified Adviser ↔ Cereno Scientific DNB Carnegie Investment Bank AB is the Certified Adviser for Cereno Scientific.
Rahul Agrawal CMO and Head of R&D ↔ Cereno Scientific Rahul Agrawal is the CMO and Head of R&D at Cereno Scientific.
Sten R. Sörensen CEO ↔ Cereno Scientific Sten R. Sörensen is the CEO of Cereno Scientific.
NEWSDESK
Track Cereno Scientific live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.